|
Sydney Home
|
Archbishop Pell in protest on cloning
He joined the Anglican Archbishop of Sydney, Dr Peter Jensen, the Rev Professor James Haire of the Uniting Church, Rabbi Moshe Gutnick of the Australian Jewish Medical Federation and the Rev Tim Costello, president of the Baptist Union of Australia, and others in expressing concern at the NSW Government decision to introduce cloning legislation before uniform Commonwealth-state laws have been put in place. The leaders say in an open letter to the Federal, State and Territory governments: “We advise ... that producing human embryos by a cloning process or any other method of non-sexual reproduction … produces a laboratory embryo with no parents or guardians, in fact, no one concerned to protect his or her interests. “All such embryos would be likely to be destroyed.” The letter, whose 80 signatories include other religious leaders, surgeons, barristers and bio-ethicists, asks for appropriate national standards for medical research in the area. It says: “The supposed distinction between ‘therapeutic’ and ‘reproductive’ cloning must be exposed for the furphy it is: to produce an embryo is always ‘reproductive’; to destroy an embryo is never ‘therapeutic’. “So-called ‘therapeutic cloning’ involves the manufacture of a new race of laboratory humans with the intention, right from the beginning, to exploit and destroy them as if they were laboratory animals. This would be the worst of all possible uses of the cloning technology. “We urge (political leaders) to ensure that there are effective nationwide prohibitions on unethical alternatives such as the production and destruction of human embryos for experimental purposes, and the creation of a market for unethically procured embryonic stem cells. “We ask our political leaders to have regard for the sacredness of all human beings, of whatever level of maturity, dependency or ability. “We ask them to support adult stem cell research and to reject a policy of destroying some to treat others.” The open letter argues that using a patient’s own tissues as a source of stem cells is safer, “especially as they have much greater direct therapeutic potential in terms of tissue compatibility”
|